Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Karuna and Incyte scrap programs; More cash for the SPACs
Endpoints
Wed, 08/5/20 - 12:02 am
Tags:
Karuna Therapeutics, Eli Lilly, Incyte, SPAC
Lilly to test COVID-19 antibody drug in unorthodox nursing home study
BioPharma Dive
Mon, 08/3/20 - 10:51 am
Tags:
Eli Lilly, clinical trials, antibodies, nursing homes, COVID-19
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
BioSpace
Fri, 07/31/20 - 10:40 am
Tags:
Boehringer Ingelheim, Eli Lilly, Jardiance, heart failure, diabetes, clinical trials
Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short
Marketwatch
Thu, 07/30/20 - 11:12 am
Tags:
earnings, Eli Lilly
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort
Fierce Biotech
Thu, 07/30/20 - 11:11 am
Tags:
Eli Lilly, KRAS inhibitors, cancer
Scientists get closer to blood test for Alzheimer’s disease
Stat
Tue, 07/28/20 - 07:06 pm
Tags:
diagnostics, Alzheimer's disease, Eli Lilly
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
Tags:
R&D, drug development, Eli Lilly, Novartis, Argenx, Bristol-Myers Squibb, Vir Biotechnolgy, Biogen, GSK, Iovance, Roche
Eli Lilly’s Mirikizumab Hits the Mark in Phase III Study, Bests Cosentyx
BioSpace
Sat, 07/18/20 - 12:17 pm
Tags:
Eli Lilly, psoriasis, mirikizumab, clinical trials, Cosentyx, Novartis
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Tags:
Alzheimer's disease, Roche, Eli Lilly, AC Immune, Biohaven, Cortexyme, Biogen
Big pharma, battling COVID-19, looks to 'buy time' on another health crisis: superbugs
BioPharma Dive
Thu, 07/9/20 - 10:24 pm
Tags:
antibiotics, superbugs, Big Pharma, Eli Lilly, Antimicrobial Resistance Action Fund
AstraZeneca, Lilly, Sanofi and others raise prices to start July: report
Fierce Pharma
Wed, 07/8/20 - 10:54 am
Tags:
AstraZeneca, Eli Lilly, Sanofi, drug pricing, GSK, Biogen
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
Pharmaforum
Wed, 07/1/20 - 10:56 am
Tags:
artificial intelligence, machine learning, BenevolentAI, Eli Lilly, olumiant, COVID-19
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Mon, 06/29/20 - 10:01 am
Tags:
Big Pharma, drug development, antibiotics, innovation, Eli Lilly, Pfizer, Merck, Boehringer Ingelheim, Bayer, CARB-X
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
Tags:
migraines, physicians, Biohaven, Eli Lilly, AbbVie, Nurtec ODT, Ubrelvy, Reyvow
Third-quarter events to watch for large drug makers
EP Vantage
Mon, 06/22/20 - 10:35 am
Tags:
Biogen, aducanumab, Sanofi, THOR-707, Bristol-Myers Squibb, pegbelfermin, Eli Lilly, FDA
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Fierce Pharma
Thu, 06/18/20 - 10:40 am
Tags:
television ads, DTC ads, Merck, Eli Lilly, Amgen, drug pricing
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Wed, 06/17/20 - 09:52 pm
Tags:
Eli Lilly, migraines, Amgen, Teva Pharmaceutical, Lundbeck, Emgality
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Wed, 06/17/20 - 09:57 am
Tags:
Novartis, Eli Lilly, Cosentyx, Taltz, spondyloarthritis
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
TheStreet.com
Tue, 06/16/20 - 10:52 am
Tags:
Eli Lilly, Verzenio, breast cancer, clinical trials
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Forbes
Mon, 06/15/20 - 10:54 am
Tags:
Eli Lilly, COVID-19, pandemic, clinical trials, baricitinib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.